Sponsors & Exhibitors

9th RWE, Market Access, Pricing & Reimbursement Global Congress 2023 Europe

Trends and Strategies to Achieve Optimum Patient Access to Healthcare

4th - 5th May 2023 - Copthorne Tara Hotel London Kensington, London, UK

IGES UK Pharma and Optimax access are UK based and members of the IGES Lifesciences group based in Germany. Both UK based companies provide strategic support for the market entry of new innovations in the UK as well as Health Economics and Outcome Research (HEOR) consulting under one roof, helping organisations with HTA submissions. With over 25 NICE submissions and approvals covering over 14 disease areas and over 50 publications, including over 100 economic models for the NHS, the experience within the team is very strong. In addition, there is over 30 years’ experience in pharmaceutical commercialisation including utilising public and policy driven levers to ensure launch excellence.

Certara accelerates medicines using proprietary biosimulation software, technology, and teams of pharmaceutical development experts with broad and complementary expertise to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.

Available Shortly. 

Decisive Consulting set out to bring the curiosity, capability, and capacity companies need at “Decisive Moments” of their evolution – not just ideas and plans, but active support where it’s needed and to harness the power of rebel thinking for better decisions.

We are driven by a core belief that Patient Access is everyone’s business. By taking an “access first” lens to development projects and commercial strategy we enable our clients to plan for what matters most – making sure promising technologies and treatments reach those they are designed to support.

We believe that our focus on the “what” and the “how” is one of the aspects that sets us apart. We have the lived experience of senior industry roles, coupled with razor sharp insight and can move swiftly from plans to actions. We are ready to walk with our clients in implementing plans and programme as well as developing the core strategies that drive them.

Decisive aims to enable better decision making through development by bringing an “access first” lens to strategy, and to leave business better equipped for what comes next.

Optimax Access is a UK-based Health Economics and Outcome Research (HEOR) consultancy company based in the United Kingdom, with an office in the Netherlands as well. We assist our clients in introducing their pharmaceutical and biotech products, and services to major global healthcare markets. We will help you to identify a clear and optimal pathway to success with a comprehensive catalog of services ranging from clinical study design to reimbursement assessment, health economics evidence generation and health technology assessment dossier submission.

Optimax Access has been a preferred business partner for HEOR services for iGES Life Sciences Group (a 40-year-old company based in Germany with multiple offices in Europe) since 2019.

Interested in Sponsoring or Exhibiting?

Our event partners and team of experts are recognized for creating and providing unique, innovative events. We open doors and create access to business opportunities for our clients. Our events are forum for discussion, learning, showcasing new technologies, innovations, new products and trends, solutions and concepts.

The impact you make and how you get your message across at our Paradigm Global Events is up to you – we offer packages or tailor made solutions to meet your exact requirements and budget.

By sponsoring a Paradigm Global Event you will be exposed to the following:

Solution Showcase

Showcase your latest cutting-edge solutions, new products, technology, innovations and trend. Meet face to face with high level decision makers who are in a receptive mindset and actively seeking solutions and services.

As an exhibitor you will gain access to this exclusive captive audience and have the opportunity to:

Scroll to Top